This narrative review aims to synthesize current knowledge on predictive factors influencing the efficacy of ADCs, including key biomarkers, such as HER2 and TROP-2 expression, hormone receptor (HR) status, and the tumor microenvironment. This evidence concerns the gene TACSTD2 and neoplasm.